Table 2.
Results of cystometric parameters, showing a decrease in ICI, Bcap, and Bcom in the CBI group
| Parameter | Control (n = 8) | CBI (n = 8) | CBI + mirodenafil (n = 8) |
|---|---|---|---|
| BP (mmHg) | 3.4 ± 0.8 | 3.6 ± 0.5 | 3.3 ± 0.3 |
| TP (mmHg) | 10.8 ± 1.5 | 11.8 ± 0.6 | 10.9 ± 0.8 |
| MP (mmHg) | 28.2 ± 2.5 | 27.2 ± 0.4 | 29.2 ± 1.0 |
| TP–BP (mmHg) | 7.4 ± 1.3 | 8.2 ± 0.9 | 7.6 ± 0.5 |
| ICI (min) | 5.3 ± 1.2a) | 2.1 ± 0.5 | 4.2 ± 1.0b) |
| Bcap (mL) | 1.1 ± 0.06a) | 0.4 ± 0.03 | 0.9 ± 0.04b) |
| Bcom (mL/mmHg) | 0.15 ± 0.02a) | 0.05 ± 0.04 | 0.12 ± 0.03b) |
Values are presented as the mean±standard deviation.
ICI, intercontraction interval; Bcap, bladder capacity (infusion rate/micturition frequency); Bcom, bladder compliance (Bcap/[TP–BP]); CBI, chronic bladder ischemia; BP, baseline pressure; TP, threshold pressure; MP, maximum pressure.
a)
Higher in control group vs. CBI group (P<0.05).
b)
Higher in CBI group vs. CBI+mirodenafil group (P<0.05).